Artificial Intelligence Empowered Anesthesia Ultrasound Guided Regional Anesthesia Training
Launched by TONGJI HOSPITAL · Aug 6, 2024
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how artificial intelligence (AI) can improve training for anesthesiologists in using ultrasound for regional anesthesia. Regional anesthesia is a technique that numbs a specific area of the body, often used during surgeries. The goal of the study is to see if using AI can make this training more effective, helping doctors learn how to perform these procedures better and more safely.
To participate in the trial, individuals must be between the ages of 65 and 74 and be able to give their consent by signing a form. It’s important to note that people who have allergies to ultrasound gel or other related products will not be eligible to join. If you decide to participate, you can expect to engage in training sessions that use AI technology to improve the learning process. The trial is not yet recruiting participants, but it is an exciting opportunity to help advance medical training in anesthesia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntary participants;
- • Sign the informed consent form.
- Exclusion Criteria:
- • allergic to ultrasound coupling agents
About Tongji Hospital
Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology, is a leading medical institution in China dedicated to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary team of experts, Tongji Hospital focuses on translating scientific discoveries into effective treatments and therapies. The hospital is committed to enhancing patient care by conducting rigorous clinical trials that adhere to the highest ethical and regulatory standards, fostering collaboration with both national and international research communities to drive medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
mujun Chang, Dr.
Study Chair
Tongji Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported